News and Events | Aviceda Therapeutics

Sep 24, 2024  · Aviceda Therapeutics Announces Formation of Renowned European Clinical Advisory Board The European Clinical Advisory Board brings together top internationally …


Install CouponFollow Chrome Extension   CouponFollow Extension

$207
OFF

Aviceda Raises $207M For Geographic Atrophy Drug's Ph. 3 Journey

3 weeks from now

Jan 7, 2025  · Aviceda Therapeutics has secured $207.5 million in series C funds as the immunomodulator-focused biotech awaits a phase 3 readout this year for its lead eye disease …

fiercebiotech.com

$207
OFF

Aviceda Raises $207.5m For Eye Drug, And Other Financings

3 weeks from now

Jan 8, 2025  · Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug for sight-robbing disease geographic atrophy (GA) into …

pharmaphorum.com

$207
OFF

Aviceda Therapeutics Raises Upsized $207.5 Million In Series C ...

3 weeks from now

CAMBRIDGE, Mass., January 07, 2025--Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round

yahoo.com

$207
OFF

Aviceda Therapeutics Raises Upsized $207.5 Million In Series C ...

3 weeks from now

Jan 7, 2025  · This raise reflects the strong conviction from investors in Aviceda’s lead program AVD-104 for geographic atrophy—a market poised for disruption and an improved standard of …

businesswire.com

$207
OFF

Aviceda Therapeutics Raises $207.5 Million To Advance Lead …

3 weeks from now

Jan 8, 2025  · Aviceda Therapeutics announced the closing of a $207.5 million Series C financing to propel the company’s pivotal phase 3 clinical trial for AVD-104, a treatment candidate for …

eyewire.news

$207
OFF

Aviceda Raises $207M Series C To Take Geographic Atrophy Drug …

3 weeks from now

Jan 7, 2025  · Aviceda Therapeutics has secured $207.5 million in series C funds as the immunomodulator-focused biotech awaits a phase 3 readout this year for its lead eye disease …

biotechnetworks.org

$207
OFF

Aviceda Therapeutics: $207.5 Million (Series C) Raised To Develop …

3 weeks from now

Jan 8, 2025  · Aviceda Therapeutics, a private, clinical-stage biotech company focused on developing next-generation immunomodulators with a proprietary High Affinity Ligands of …

pulse2.com

$10
OFF

NVIDIA Partners With Industry Leaders To Advance Genomics, …

3 weeks from now

Jan 13, 2025  · NVIDIA today announced new partnerships to transform the $10 trillion healthcare and life sciences industry by accelerating drug discovery, enhancing genomic research and …

nvidia.com

$400000
OFF

Official Site Of The State Of New Jersey - The Official Web Site For ...

3 weeks from now

Jan 18, 2024  · The company will focus on building their digital proprietary platform and easy to use digital application. Thrivio Health, North Bergen – $400,000 Thrivio Health offers an AI …

nj.gov

$1
OFF

Hudson-Bergen Light Rail To Get New Operator In Major $1.5 …

3 weeks from now

Dec 4, 2024  · ACI-Herzog JV has been awarded a $1.5 billion contract to operate and maintain New Jersey’s Hudson-Bergen Light Rail system.

jerseydigs.com


Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension